Monitor for additional insider selling in the next quarter; isolated transactions of this size are routine, but a growing trend could signal caution. No immediate trading signal.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $256.94entry
- T+1 · 9mo ago +0.32%α +1.23% · $257.75
- T+5 · 8mo ago −1.90%α −0.69% · $252.06
- T+20 · 8mo ago −14.38%α −6.44% · $220.00
- T+60 · 6mo ago −19.05%α −28.38% · $207.98
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two ResMed insiders, including CFO Brett Sandercock, sold shares in the past week, totaling $774,740 in open-market transactions. The sales are modest in absolute value and represent a very small fraction of the company's $37.7B market cap.
Key Financial Metrics
Key Facts
- CFO Brett Sandercock sold 1,000 shares for $254,300 in an open-market transaction.
- Peter C. Farrell sold 2,000 shares for $520,440 in an open-market transaction.
- Total insider sales in the past 7 days: $774,740.
- All transactions were open-market sales (P code equivalents), not driven by derivatives or tax events.
- Total sales represent only 0.002% of ResMed's $37.7B market capitalization.
Financial Impact
$774,740 in total open-market share sales by insiders
Risk Factors
- Perception risk if media or retail investors interpret CFO selling as negative, despite minimal dollar impact.
- Potential for follow-on selling if more insiders exit positions near current price levels.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-RMD-1772740336109 |
Track record
19 reports on RMD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $239.53 +2.32% settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $239.53 +4.17% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $239.53 −0.27% ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $239.53 +5.65% ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $239.53 +9.43% ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $239.53 +9.43% ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $239.53 +9.43% No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $239.53 +9.09% ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $239.53 +6.53% ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers